We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. PACS Group, Inc. is one of them.
PACS Group, Inc. (NYSE:PACS), a leading post-acute care provider, has been in focus this September amid regulatory challenges and operational growth. The Utah-based company operates 316 facilities across 17 states, with more than 32,000 skilled nursing beds and 2,400 assisted living beds, emphasizing quality care. Most facilities hold 4- or 5-star CMS ratings. Since Q2 2024, PACS has expanded rapidly, adding 96 facilities to its portfolio.
In September, the New York Stock Exchange extended PACS’s trading period to November 19, 2025, giving the company more time to complete restatements of financial statements from early and mid-2024 and catch up on SEC filings. PACS Group, Inc. (NYSE:PACS) is also cooperating with an independent Audit Committee investigation into past financial matters. Despite these issues, management signaled strong momentum, projecting record revenue and adjusted EBITDA for the first half of 2025 once filings are complete. As of June 30, the business reported 88.9% occupancy, well above the industry’s 78% average, and cash reserves of $294.2 million, nearly double year-end 2024 levels, making it a company to watch among stocks with insider buying.
Leadership changes also marked the month, with CFO Derick Apt resigning after an internal policy investigation. PACS Group, Inc. (NYSE:PACS) appointed a former CFO as interim and added an interim compliance chief to strengthen governance and regulatory oversight.
While we acknowledge the potential of PACS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW
Disclosure: None.